Amgen is providing this page as a service to our customers and others seeking Amgen safety data sheet (SDS) information. Information in each SDS addresses potential exposures of healthcare workers and others who may be exposed to our products in the workplace. SDSs should not be used as a replacement for, or as a supplement to, prescribing information (PI) or the advice of a healthcare professional.
To the best of our knowledge, the information provided in each SDS is accurate, and based on data available to Amgen, as of the date of the Safety Data Sheet. Each SDS available through this webpage may not have been updated with information that became available after its publication. The information in each SDS is specific to the material that is the subject of that SDS and may not be valid when the material is used in combination with any other materials or in any process. Each user should review the information provided in the SDS in context of the user's intended manner of handling, use, processing, storing, transporting, and disposing of the material.
No representation, warranty, or guarantee, express or implied (including a warranty of fitness or merchantability for a particular purpose or noninfringement), is made with respect to the materials, the accuracy of this information, the results to be obtained from the use thereof, or the hazards connected with the use of the material.
By clicking on an SDS link, you accept these terms and conditions. To view a specific product SDS, click on the appropriate link below:
- ACTIMMUNE® (interferon gamma-1b)
- Aimovig™ (erenumab-aooe)
- AMJEVITA™ (adalimumab-otto)
- Aranesp® (darbepoetin alfa)
- AVSOLA™ (infliximab-axxq)
- BLINCYTO® (blinatumomab)
- BUPHENYL® (sodium phenylbutyrate)
- Corlanor® (ivabradine)
- Enbrel® (etanercept)
- EPOGEN® (epoetin alfa)
- EVENITY™ (romosozumab-aqqg)
- IMDELLTRA™ (tarlatamab-dlle)
- IMLYGIC® (talimogene laherparepvec)
- KANJINTI™ (trastuzumab-anns)
- KRYSTEXXA® (pegloticase)
- Kyprolis® (carfilzomib)
- LUMAKRAS™ (sotorasib)
- MVASI™ (bevacizumab-awwb)
- Neulasta® (pegfilgrastim)
- NEUPOGEN® (filgrastim)
- Nplate® (romiplostim)
- Otezla® (apremilast)
- Parsabiv™ (etelcalcetide)
- PROCYSBI® (cysteamine bitartrate)
- Prolia® (denosumab)
- RAVICTI® (glycerol phenylbutyrate)
- Repatha® (evolocumab)
- RIABNI™ (rituximab-arrx)
- Sensipar® (cinacalcet)
- Tavneos® (avacopan)
- TEPEZZA® (teprotumumab-trbw)
- Tezspire™ (tezepelumab-ekko)
- UPLIZNA® (inebilizumab-cdon)
- Vectibix® (panitumumab)
- XGEVA® (denosumab)